is allulose a glp 1 agonist GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose This sweetener actually triggers GLP-1??

Application Lipolytic Reducer and Figure Shaper

Liver function tests, insulin and blood sugar levels, PSA for cancer screening, and cortisol

It is known for its regenerative properties, aiding in muscle recovery and healing without significant side effects

Eur Rev Med Pharmacol Sci (2017) 21(9):226873

In terms of side effects and tolerability, the advantage goes to PT-141

In addition, exenatide was shown to activate GLP-1R and inhibit the PI3K/AKT pathway to inhibit the growth, migration, and invasion of ovarian cancer cells, and promote cell apoptosis, thereby producing anticancer effects on diabetic patients with ovarian cancer (218)